Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSchorn, Stephan
dc.contributor.authorVogel, Thomas
dc.contributor.authorDemir, Ihsan Ekin
dc.contributor.authorDemir, Elke
dc.contributor.authorSafak, Okan
dc.contributor.authorFriess, Helmut
dc.contributor.authorCeyhan, Guralp Onur
dc.date.accessioned2025-10-16T15:20:16Z
dc.date.issued2020
dc.identifier.doi10.1016/j.pan.2020.10.043
dc.identifier.otherWOS:000597983100029
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7491
dc.publisherELSEVIER
dc.sourcePANCREATOLOGY
dc.titleDo somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials
dc.typeReview

Dosyalar

Koleksiyonlar

WOS